Register to receive a free Urological Devices Market Report Suite for U.S. synopsis and brochure Boston Scientific announced that it has entered into a definitive agreement to acquire Augmenix, Inc., a privately-held company which has developed and commercialized the SpaceOAR® System, a therapy used to reduce common and debilitating side effects that men may experience after receiving
Boston Scientific Announces Agreement To Acquire Augmenix, Inc.
